Related Experiment Videos
Expression of tissue-specific genes in transgenic mice
K Yamamura1, S Wakasugi, T Iwanaga
1Institute for Medical Genetics, Kumamoto University Medical School, Japan.
Summary
Researchers created a transgenic mouse model for familial amyloidotic polyneuropathy by introducing a human mutant transthyretin gene. This model shows amyloid deposition, confirming its utility for studying human genetic diseases.
Area of Science:
- Genetics
- Molecular Biology
- Pathology
Background:
- Transgenic mouse models are crucial for studying gene regulation and human diseases.
- Familial amyloidotic polyneuropathy (FAP) is a dominantly inherited disease linked to mutations in the transthyretin (TTR) gene.
Purpose of the Study:
- To develop a transgenic mouse model for FAP using the human mutant TTR gene.
- To analyze the tissue-specific and developmental regulation of the introduced mutant gene in vivo.
Main Methods:
- Microinjection of the cloned human mutant transthyretin gene into mouse germ line.
- Generation and analysis of transgenic mice for amyloid deposition and gene expression patterns.
Main Results:
- Transgenic mice exhibited amyloid deposition in the alimentary tract mucosa and renal glomeruli.
- The expression of the mutant TTR gene appeared normally regulated during development.
- The adult onset of the disease in this model is not attributed to dysregulated gene expression.
Conclusions:
- The developed transgenic mouse successfully models human FAP, demonstrating amyloid pathology.
- This model supports the hypothesis that normal developmental regulation of the mutant TTR gene occurs.
- The findings suggest that factors other than developmental dysregulation contribute to the adult onset of FAP.